Lithium carbonate in the treatment of two patients with infantile autism and atypical bipolar symptomatology

Jacob Kerbeshian, Larry Burd, Wayne Fisher

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Two patients with infantile autism by DSM-III criteria and with atypical bipolar symptomatology were treated with lithium carbonate. Both children demonstrated a significant response with levels above 1.0mEq/liter. Factors that may be useful in discovering patients with autism who may respond to lithium treatment include a family history of bipolar illness; extreme hyperactivity not responsive to a stimulant; a definite cyclic component to symptomatic behaviors; sustained laughter, irritability, or giddiness that is not stereotypic; and/or the presence of many or all of the symptom criteria for bipolar disorder.

Original languageEnglish (US)
Pages (from-to)401-405
Number of pages5
JournalJournal of Clinical Psychopharmacology
Volume7
Issue number6
StatePublished - Dec 1987

Fingerprint

Lithium Carbonate
Autistic Disorder
Laughter
Dizziness
Bipolar Disorder
Lithium
Diagnostic and Statistical Manual of Mental Disorders
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Lithium carbonate in the treatment of two patients with infantile autism and atypical bipolar symptomatology. / Kerbeshian, Jacob; Burd, Larry; Fisher, Wayne.

In: Journal of Clinical Psychopharmacology, Vol. 7, No. 6, 12.1987, p. 401-405.

Research output: Contribution to journalArticle

@article{68e8cc20f7be436d85e2b41a5baf4630,
title = "Lithium carbonate in the treatment of two patients with infantile autism and atypical bipolar symptomatology",
abstract = "Two patients with infantile autism by DSM-III criteria and with atypical bipolar symptomatology were treated with lithium carbonate. Both children demonstrated a significant response with levels above 1.0mEq/liter. Factors that may be useful in discovering patients with autism who may respond to lithium treatment include a family history of bipolar illness; extreme hyperactivity not responsive to a stimulant; a definite cyclic component to symptomatic behaviors; sustained laughter, irritability, or giddiness that is not stereotypic; and/or the presence of many or all of the symptom criteria for bipolar disorder.",
author = "Jacob Kerbeshian and Larry Burd and Wayne Fisher",
year = "1987",
month = "12",
language = "English (US)",
volume = "7",
pages = "401--405",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Lithium carbonate in the treatment of two patients with infantile autism and atypical bipolar symptomatology

AU - Kerbeshian, Jacob

AU - Burd, Larry

AU - Fisher, Wayne

PY - 1987/12

Y1 - 1987/12

N2 - Two patients with infantile autism by DSM-III criteria and with atypical bipolar symptomatology were treated with lithium carbonate. Both children demonstrated a significant response with levels above 1.0mEq/liter. Factors that may be useful in discovering patients with autism who may respond to lithium treatment include a family history of bipolar illness; extreme hyperactivity not responsive to a stimulant; a definite cyclic component to symptomatic behaviors; sustained laughter, irritability, or giddiness that is not stereotypic; and/or the presence of many or all of the symptom criteria for bipolar disorder.

AB - Two patients with infantile autism by DSM-III criteria and with atypical bipolar symptomatology were treated with lithium carbonate. Both children demonstrated a significant response with levels above 1.0mEq/liter. Factors that may be useful in discovering patients with autism who may respond to lithium treatment include a family history of bipolar illness; extreme hyperactivity not responsive to a stimulant; a definite cyclic component to symptomatic behaviors; sustained laughter, irritability, or giddiness that is not stereotypic; and/or the presence of many or all of the symptom criteria for bipolar disorder.

UR - http://www.scopus.com/inward/record.url?scp=0023492514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023492514&partnerID=8YFLogxK

M3 - Article

C2 - 3429701

AN - SCOPUS:0023492514

VL - 7

SP - 401

EP - 405

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 6

ER -